Refractory ALK-Positive Anaplastic Large Cell Lymphoma: Long Term Survival with Crizotinib
Crossref DOI link: https://doi.org/10.1007/s12288-017-0889-6
Published Online: 2017-11-04
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ganesan, Prasanth http://orcid.org/0000-0003-2762-6591
Joshua, Thanda
Sundersingh, Shirley
Sagar, Tenali Gnana
License valid from 2017-11-04